✦ LIBER ✦

Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer

✍ Scribed by Yoshinori Ito; Koichi Nagasaki; Yoshio Miki; Takuji Iwase; Futoshi Akiyama; Masaaki Matsuura; Rie Horii; Masujiro Makita; Nahomi Tokudome; Masaru Ushijima; Masataka Yoshimoto; Shunji Takahashi; Tetsuo Noda; Kiyohiko Hatake

Book ID: 108586893
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 217 KB
Volume: 102
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2010.01740.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is ERBB-2 A predictive marker for respon

Is ERBB-2 A predictive marker for response to primary chemotherapy for operable breast cancer: a prospective study in a phase ii randomized trial of doxorubicin/cyclophosphamide (AC) and doxorubicin/paclitaxel (AT)

✍ P. De Crémoux; V. Diéras; V. Le Doussal; A. Vincent-Salomon; M. Tubiana-Hulin; J 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 120 KB